Sign inSubscribe

indication directory

Heart Failure clinical trial intelligence

Trials are included only when the source condition or controlled indication mapping directly matches this disease area. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

indication

Association rule

source condition

NCT00990665
Source recordAI-normalized

Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study

The Promote Q CRT-D and Quartet LV lead study, sponsored by Abbott Medical Devices, aimed to evaluate the safety and efficacy of a new cardiac resynchronization therapy device in patients with heart failure. The study enrolled 178 participants and was completed in July 2012.

AI analysis

Indication: Heart Failure

Modality: medical device

Target: Heart Failure

Sponsor: Abbott Medical Devices

Source URL: ClinicalTrials.gov

Source updated: Feb 27, 2019

Ingested: May 30, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by conditions: Heart Failure

View original source fields

Condition raw: Heart Failure

Condition normalized: Heart Failure

Modality raw: Heart Failure

Modality normalized: medical device

Target raw: Heart Failure

Target normalized: Heart Failure

Open report